Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Crossroads Cancer Center
mi
from
Effingham, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Crossroads Cancer Center
mi
from
Effingham, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Northwestern Medicine Cancer Center Delnor
mi
from
Geneva, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Northwestern Medicine Cancer Center Delnor
mi
from
Geneva, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Community Cancer Center Foundation
mi
from
Normal, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Community Cancer Center Foundation
mi
from
Normal, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Mid-Illinois Hematology Oncology Associates Limited
mi
from
Normal, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Mid-Illinois Hematology Oncology Associates Limited
mi
from
Normal, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Ottawa Regional Hospital and Healthcare Center
mi
from
Ottawa, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Ottawa Regional Hospital and Healthcare Center
mi
from
Ottawa, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
mi
from
Pekin, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
mi
from
Pekin, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
OSF Saint Francis Medical Center
mi
from
Peoria, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Northwestern Medicine Cancer Center Warrenville
mi
from
Warrenville, IL
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Northwestern Medicine Cancer Center Warrenville
mi
from
Warrenville, IL
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
IU Health La Porte Hospital
mi
from
La Porte, IN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
IU Health La Porte Hospital
mi
from
La Porte, IN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Saint Joseph Regional Medical Center-Mishawaka
mi
from
Mishawaka, IN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Saint Joseph Regional Medical Center-Mishawaka
mi
from
Mishawaka, IN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Siouxland Regional Cancer Center
mi
from
Sioux City, IA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Siouxland Regional Cancer Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Saint Luke's Regional Medical Center
mi
from
Sioux City, IA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Saint Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Kansas City NCI Community Oncology Research Program
mi
from
Prairie Village, KA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Kansas City NCI Community Oncology Research Program
mi
from
Prairie Village, KA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Wichita NCI Community Oncology Research Program
mi
from
Wichita, KA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Wichita NCI Community Oncology Research Program
mi
from
Wichita, KA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Baptist Health Corbin
mi
from
Corbin, KY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Baptist Health Corbin
mi
from
Corbin, KY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Ochsner Medical Center Jefferson
mi
from
New Orleans, LA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Ochsner Medical Center Jefferson
mi
from
New Orleans, LA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Steward Saint Elizabeth's Medical Center
mi
from
Brighton, MA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Steward Saint Elizabeth's Medical Center
mi
from
Brighton, MA
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Michigan Cancer Research Consortium NCORP
mi
from
Ann Arbor, MI
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Michigan Cancer Research Consortium NCORP
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Saint Mary Mercy Hospital
mi
from
Livonia, MI
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Saint Mary Mercy Hospital
mi
from
Livonia, MI
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Lakeland Community Hospital
mi
from
Niles, MI
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Lakeland Community Hospital
mi
from
Niles, MI
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Saint Joseph Mercy Oakland
mi
from
Pontiac, MI
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Saint Joseph Mercy Oakland
mi
from
Pontiac, MI
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Lakeland Hospital
mi
from
Saint Joseph, MI
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Lakeland Hospital
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Metro Minnesota Community Oncology Research Consortium
mi
from
Saint Louis Park, MN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Metro Minnesota Community Oncology Research Consortium
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Liberty Radiation Oncology Center
mi
from
Liberty, MO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Liberty Radiation Oncology Center
mi
from
Liberty, MO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Cancer Research for the Ozarks NCORP
mi
from
Springfield, MO
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Cancer Research for the Ozarks NCORP
mi
from
Springfield, MO
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Billings Clinic Cancer Center
mi
from
Billings, MT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Billings Clinic Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Montana Cancer Consortium NCORP
mi
from
Billings, MT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Montana Cancer Consortium NCORP
mi
from
Billings, MT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Frontier Cancer Center and Blood Institute-Billings
mi
from
Billings, MT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Frontier Cancer Center and Blood Institute-Billings
mi
from
Billings, MT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Saint Peter's Community Hospital
mi
from
Helena, MT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Saint Peter's Community Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Montana Cancer Specialists
mi
from
Missoula, MT
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Montana Cancer Specialists
mi
from
Missoula, MT
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
CHI Health Good Samaritan
mi
from
Kearney, NE
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
CHI Health Good Samaritan
mi
from
Kearney, NE
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Missouri Valley Cancer Consortium
mi
from
Omaha, NE
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Alegent Health Immanuel Medical Center
mi
from
Omaha, NE
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Alegent Health Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Inspira Medical Center Vineland
mi
from
Vineland, NJ
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Inspira Medical Center Vineland
mi
from
Vineland, NJ
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Hematology Oncology Associates of Central New York-Auburn
mi
from
Auburn, NY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Hematology Oncology Associates of Central New York-Auburn
mi
from
Auburn, NY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Hematology Oncology Associates of Central New York-Rome
mi
from
Rome, NY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Hematology Oncology Associates of Central New York-Rome
mi
from
Rome, NY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
State University of New York Upstate Medical University
mi
from
Syracuse, NY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Hematology Oncology Associates of Central New York-Onondaga Hill
mi
from
Syracuse, NY
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Hematology Oncology Associates of Central New York-Onondaga Hill
mi
from
Syracuse, NY
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Southern Oncology Specialists-Charlotte
mi
from
Charlotte, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Southern Oncology Specialists-Charlotte
mi
from
Charlotte, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Hendersonville Hematology and Oncology at Pardee
mi
from
Hendersonville, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Hendersonville Hematology and Oncology at Pardee
mi
from
Hendersonville, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Margaret R Pardee Memorial Hospital
mi
from
Hendersonville, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Margaret R Pardee Memorial Hospital
mi
from
Hendersonville, NC
Click here to add this to my saved trials
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated:  11/21/2017
Southern Oncology Specialists-Huntersville
mi
from
Huntersville, NC
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 11/21/2017
Southern Oncology Specialists-Huntersville
mi
from
Huntersville, NC
Click here to add this to my saved trials